Sep 07, 2022 / 06:35PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with Dexcom. With us, we have Jereme Sylvain, Executive Vice President and CFO; and Matt Carey of Investor Relations. In terms of format, it's going to be a fireside chat. If anyone has a question they want to ask, just raise your hand, and we'll call on you. Jereme, thanks so much for being here.
Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO
Thanks for having us, Larry. Thanks, everyone, for joining us today. It's good to see so many faces.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystSo we've been starting with the macro environment and even though the macro environment hasn't affected you that much, Dexcom that much, you still have had some
Trustpilot
